RUMORED BUZZ ON DICLOFENAC SODIUM

Gastrointestinal (GI): NSAIDs that block COX-one activity have correlations with GI problems mainly because of the inhibition from the synthesis of gastroprotective brokers for instance PGE2 along with other prostaglandins. This inhibition contributes to lowered mucin generation by gastric epithelial cells, fewer bicarbonate secretion, and less epi